Showing 1 - 1 results of 1 for search 'Ryusuke Suzuki', query time: 0.01s Refine Results
  1. 1
    HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in EGFR-mutant lung adenocarcinoma cells

    HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in EGFR-mutant lung adenocarcinoma cells by Hanbing Lyu, Akihiko Ishimura, Ryusuke Suzuki, Khurelsukh Buyanbat, Gerelsuren Batbayar, Makiko Meguro-Horike, Shin-ichi Horike, Seiji Yano, Takeshi Suzuki

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: